Tech Company Financing Transactions

Landos Biopharma Funding Round

Perceptive Advisors, RTW Investments and Osage Partners participated in a $60 million Series B capital raise for Landos Biopharma. The round was announced on 8/14/2019.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

1800 Kraft Dr. 216
Blacksburg, VA 24060
USA

Phone

Undisclosed

Website

www.landosbiopharma.com

Email Address

[email protected]

Overview

Landos' unique core platform technology enables accelerated development of safer, more effective oral, first-in-class therapeutics for autoimmune diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Josep Bassaganya-Riera

        

Chief Medical Officer

Simon Lichtiger

        

Chief Scientific Officer

Raquel Hontecillas

        

Chief Scientific Officer

Andrew Leber

        

VP - Finance

Jennifer Collette

        

VP - Regulatory Affairs

Jyoti Chauhan

        

Browse more venture capital transactions:

Prev: 8/14/2019: GroundMetrics venture capital transaction
Next: 8/14/2019: ChronWell venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary